
zzso infections are the most common infectious cause of death among patients with zzso zzso Conventional zzso agents have limited activity and a narrow therapeutic zzso In an zzso study we assessed the activity of an oral zzso zzso zzso in the treatment of zzso life-threatening mold infections in 50 patients with cancer, most of whom had previously received zzso B and/or zzso zzso zzso was given at a daily dose of zzso zzso for a median of 8 zzso The overall rate of response was zzso among 34 zzso patients, with a complete response in 22 instances and a partial response in zzso Some patients responded despite persistent, profound zzso Three patients developed zzso and two developed zzso zzso zzso zzso was well zzso We conclude that oral zzso such as zzso zzso may represent effective and safe treatment of mold infections in zzso patients, at least after standard zzso zzso Unfortunately, the zzso potential of zzso zzso in animals has precluded its zzso Our hope is that zzso with similar efficacy but without zzso potential can be zzso 

